Anzeige
Mehr »
Donnerstag, 23.10.2025 - Börsentäglich über 12.000 News
Das Comeback des Goldrauschs - diesmal ausgelöst durch eine Währungskrise
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JTC2 | ISIN: FR0011184241 | Ticker-Symbol: A89
Tradegate
23.10.25 | 17:54
8,460 Euro
-2,20 % -0,190
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
ADOCIA SAS Chart 1 Jahr
5-Tage-Chart
ADOCIA SAS 5-Tage-Chart
RealtimeGeldBriefZeit
8,4608,53018:04
8,4608,53017:54

Aktuelle News zur ADOCIA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15.10.ADOCIA Reports Third Quarter 2025 Financial Results and Provides a Business Update272Cash position of €13.4 million as of September 30, 2025 US$10 million milestone payment from partner Tonghua Dongbao and 2024 Research Tax Credit of €2.8 million received in July 2025 ...
► Artikel lesen
15.10.ADOCIA and Tonghua Dongbao Announce Positive Topline Results of Phase 3 Clinical Trial on Ultra-Rapid Insulin BioChaperone Lispro (THDB0206 injection) in people with T1D367This Phase 3 clinical trial on BioChaperone Lispro (THDB0206 injection) conducted in China in people with Type 1 Diabetes, successfully demonstrated, in comparison with standard of care Humalog: ...
► Artikel lesen
10.10.Number of Shares and Voting Rights of ADOCIA as of September 30th, 2025205Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French "Code de Commerce" and article 223-16 of the General Regulation of the French stock-market authorities (Autorité...
► Artikel lesen
25.09.ADOCIA Announces First Half 2025 Financial Results and Provides a Business Update366Cash position of €7.1m (million) as of June 30, 2025 following successful completion of €9.7m private placement in February 2025 Cash runway secured until Q2 2026 considering the US$10...
► Artikel lesen
11.09.Number of Shares and Voting Rights of ADOCIA as of August 31st, 2025274Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French "Code de Commerce" and article 223-16 of the General Regulation of the French stock-market authorities (Autorité...
► Artikel lesen
03.09.ADOCIA Announces Oral Presentations on AdoShell and BioChaperone at EASD, ESB and PODD 2025 Annual Meetings1.981Regulatory News: Adocia (Euronext Paris: FR0011184241 ADOC, the "Company"), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions...
► Artikel lesen
19.08.Number of Shares and Voting Rights of ADOCIA as of July 31st, 2025311Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French "Code de Commerce" and article 223-16 of the General Regulation of the French stock-market authorities (Autorité...
► Artikel lesen
ADOCIA Aktie jetzt für 0€ handeln
25.07.ADOCIA and Tonghua Dongbao Announce Positive Topline Results of Phase 3 Clinical Trial on Ultra-Rapid Insulin BioChaperone Lispro (THDB0206 injection) in People with T2D831This Phase 3 clinical trial on BioChaperone Lispro (THDB0206 injection) conducted in China in people with Type 2 diabetes, successfully demonstrated, in comparison with standard of care Humalog: ...
► Artikel lesen
23.07.ADOCIA Reports Second Quarter 2025 Financial Results and Provides a Business Update584Cash position of €7.1 million as of June 30, 2025 US$10 million milestone payment from partner Tonghua Dongbao and 2024 Research Tax Credit of €2.8 million received in July 2025 Current...
► Artikel lesen
16.07.ADOCIA Announces Half-Year Report on Adocia's Liquidity Agreement with Kepler Capital Markets423Regulatory News: Under the liquidity agreement entrusted by Adocia (Euronext Paris: FR0011184241 ADOC) to Kepler Capital Markets, the following resources were listed on the liquidity account on...
► Artikel lesen
11.07.Number of Shares and Voting Rights of ADOCIA as of June 30th, 2025344Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French "Code de Commerce" and article 223-16 of the General Regulation of the French stock-market authorities (Autorité...
► Artikel lesen
24.06.ADOCIA Presentations at ADA & IPITA Scientific Conferences Highlight Scalability and Good Translation of AdoShell from Human Islets to Stem Cell-Derived Islets351Main results are: successful scale up from animal to human device for First-In-Human study in vitro and in vivo maturation after encapsulation of immature stem cell-derived islets in...
► Artikel lesen
12.06.ADOCIA SA: Number of Shares and Voting Rights of ADOCIA as of May 31st, 2025355Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French "Code de Commerce" and article 223-16 of the General Regulation of the French stock-market authorities (Autorité...
► Artikel lesen
22.05.ADOCIA Confirms its Eligibility for the PEA-PME Scheme397Regulatory News: Adocia (Euronext Paris: FR0011184241 ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the treatment...
► Artikel lesen
21.05.ADOCIA Announces its Annual Shareholders' Meeting to be Held on June 11th, 2025 in Paris395Regulatory News: Adocia (Euronext Paris: FR0011184241 ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the treatment...
► Artikel lesen
15.05.Number of Shares and Voting Rights of ADOCIA as of April 30th, 2025310Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French "Code de Commerce" and article 223-16 of the General Regulation of the French stock-market authorities (Autorité...
► Artikel lesen
14.05.ADOCIA Reports First Quarter 2025 Financial Results and Provides a Business Update380Cash position of €12.2 million as of March 31, 2025, including €9.7m from the private placement successfully completed in February 2025 Cash runway extended until Q2 2026 Top-line...
► Artikel lesen
30.04.ADOCIA Announces the Release of its Universal Registration Document for the Year 2024364Regulatory News: Adocia (Euronext Paris: FR0011184241 ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the treatment...
► Artikel lesen
28.04.ADOCIA to Present New Data on AdoShell at Upcoming Scientific Conferences - Showcasing Potential Curative Treatment for Type 1 Diabetes342Presentations demonstrate the potential of AdoShellfor allogenic cell therapy in diabetes without immunosuppression, by delivering pancreatic human islets or iPSCs1 New preclinical data support...
► Artikel lesen
17.04.ADOCIA Announces Full Year 2024 Financial Results and Provides a Corporate and Financial Update473Cash position of €7.5m (million) as of December 31, 2024, including: €2m received from private placement in March 2024 €9.8m from an equity financing line ("PACEO") with Vester Finance ...
► Artikel lesen
Weiter >>
34 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1